Influence of T2 fluid -attenuated inversion -recovery sequence excision extension and postoperative chemotherapy in prognosis of glioblastoma
10.3760/cma.j.issn.1671-8925.2017.06.010
- VernacularTitle:T2Flair切除范围和术后辅助化疗疗程对脑胶质母细胞瘤患者预后的影响
- Author:
Ming LU
1
;
Hui ZHOU
;
Xinghai DENG
;
Jiankan LU
;
Xiaojun HE
;
Deliu LIN
;
Youming GU
;
Mingyao LAI
;
Mingming YANG
Author Information
1. 广东三九脑科医院神经外五科
- Keywords:
Glioblastoma;
T2 fluid-attenuated inversion-recovery sequence;
Extended resection;
Chemotherapy;
course
- From:
Chinese Journal of Neuromedicine
2017;16(6):591-594
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the impact of MR imaging T2 fluid-attenuated inversion-recovery sequence (MRI T2Flair) excision extension and postoperative chemotherapy in prognosis of patients with glioblastoma (GBM). Methods A retrospective study of clinical data and treatment efficacy of 17 patients with GBM, admitted to our hospital from April 2012 to August 2016, was performed. All patients were performed tumor resection by using awake anesthesia, neuroimage navigation, and intraoperative direct electrical stimulation. The impacts of the resection extent of T2Flair lesions and adjuvant chemotherapy on the prognosis of glioblastoma were analyzed. Results T1 enhanced lesions in these 17 patients were totally resected. The median follow-up duration was 18 months (8 months to 52 months). Median survival time was 20 months; the survival time of patients with resection ranges of 0%-10%, 10%-25% and more than 25% were 19, 22 and 24 months, respectively, without statistical differences (P>0.05). The patients adopted less than 6 courses chemotherapy had a 19-month-long median survival time, and those adopted 6 courses or more courses chemotherapy had a 33-month-long median survival time, with statistically significant difference (P<0.05). Conclusion When T1 enhanced lesions are totally resected, the resection extent of T2Flair lesions has no influence on patients survival time; however, patients accepted 6 or more courses of chemotherapy have a better survival.
